The pharmaceutical company said it will focus instead on a once-daily version of the pill, danuglipron, instead of starting a late-stage study of the other version.
A survey launched by the Nova Scotia College of Pharmacists on Nov. 29 is part of a bigger project to establish minimum staffing levels in community pharmacies.